GLP-1 Receptor Agonists: Expanding Horizons in Obesity Treatment

3 March 2025
3 March 2025

Table of Contents

Open Access

Efficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials

  • First Published: 27 June 2024
Efficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials

Semaglutide 2.4 mg had no statistically significant difference in the treatment effect on body weight by race or ethnicity in the STEP 1 & 3 or STEP 2 clinical trials.